Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Clinical Dentistry

Journal Scan / Research · August 20, 2022

Treatment Outcomes Following Transcrestal Maxillary Sinus Floor Elevation With an Injectable Xenogenous Bone Substitute in Gel Form

International Journal of Implant Dentistry


Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Implant Dentistry
Clinical and radiographic outcomes following transcrestal maxillary sinus floor elevation with injectable xenogenous bone substitute in gel form: a prospective multicenter study
Int J Implant Dent 2022 Jul 22;8(1)32, T Lombardi, L Lamazza, F Bernardello, G Ziętek, C Stacchi, G Troiano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading